National Institute on Drug Abuse; Notice of Closed Meetings

---
identifier: "/us/fr/2012-13750"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Institute on Drug Abuse; Notice of Closed Meetings"
title_number: 0
title_name: "Federal Register"
section_number: "2012-13750"
section_name: "National Institute on Drug Abuse; Notice of Closed Meetings"
positive_law: false
currency: "2012-06-06"
last_updated: "2012-06-06"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2012-13750"
document_type: "notice"
publication_date: "2012-06-06"
agencies:
  - "Health and Human Services Department"
  - "National Institutes of Health"
fr_citation: "77 FR 33472"
fr_volume: 77
---


#  National Institute on Drug Abuse; Notice of Closed Meetings

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:* National Institute on Drug Abuse Special Emphasis Panel Training and Career Development Subcommittee.

*Date:* June 27, 2012.

*Time:* 11:00 a.m. to 6:00 p.m.

*Agenda:* To review and evaluate grant applications.

*Place:* National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call).

*Contact Person:* Eliane Lazar-Wesley, Ph.D., Health Scientist Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 4245, MSC 9550, 6001 Executive Blvd., Bethesda, MD 20892-9550, 301-451-4530, *[email protected]* .

*Name of Committee:* National Institute on Drug Abuse Special Emphasis Panel NIDA R13 Conference Grant Review.

*Date:* June 28, 2012.

*Time:* 1:00 p.m. to 5:00 p.m.

*Agenda:* To review and evaluate grant applications.

*Place:* National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Virtual Meeting).

*Contact Person:* Minna Liang, Ph.D., Scientific Review Officer, Grants Review Branch, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 6001 Executive Blvd., Room 4226, MSC 9550, Bethesda, MD 20892-9550, 301-435-1432, *[email protected]* .

*Name of Committee:* National Institute on Drug Abuse Special Emphasis Panel Collaborative Clinical Trials in Drug Abuse (Collaborative RO1).

*Date:* June 29, 2012.

*Time:* 11:00 a.m. to 3:00 p.m.

*Agenda:* To review and evaluate grant applications.

*Place:* National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call).

*Contact Person:* Eliane Lazar-Wesley, Ph.D., Health Scientist Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 4245, MSC 9550, 6001 Executive Blvd., Bethesda, MD 20892-9550, 301-451-4530, *[email protected]* .

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS)

Dated: May 31, 2012.

Jennifer S. Spaeth,

Director, Office of Federal Advisory Committee Policy.